NAGA was proposed as a genetic risk for schizophrenia [104] because it encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which is necessary for the breakdown of glycolipids and helps to maintain and regulate the dendritic spine [111]. The gene discussed is NAGA; the disease is schizophrenia.